Jubilant Life Sciences raises Rs 350 Cr via NCDs
07 September 2018 | News
In a regulatory filing, the company said it has issued 3,500 NCDs of Rs 10,00,000 each for cash at par.
Image Source: Pexels
Jubilant Life Sciences has raised Rs 350 crore through non-convertible debentures (NCDs) on private placement basis for repayment of its existing debt and reduce the overall cost of borrowing.
In a regulatory filing, the company said it has issued 3,500 NCDs of Rs 10,00,000 each for cash at par.
The NCDs will have maturity period of 2 to 4 years and have been offered at an interest rate between 8.95 and 9.26 per cent per annum.
The NCDs will be redeemed on maturity, it added.
